这篇综述聚焦良性前列腺增生（BPH），深入探讨 TGF-β 信号通路在其中的作用。TGF-β 参与细胞增殖、分化和细胞外基质重塑，引发细胞衰老，其诱导的衰老相关分泌表型（SASP）影响疾病发展，同时 TGF-β 介导纤维化导致下尿路症状，对研究 BPH 治疗意义重大。

Estrogens and androgens have both been implicated as causes of benign prostatic hyperplasia (BPH). Although epidemiological data on an association between serum androgen concentrations and BPH are ...

前述内容由第一财经“星翼大模型”智能生成，相关AI内容力求但不保证准确性、时效性、完整性等。请用户注意甄别，第一财经不承担由此产生的任何责任。 如您有疑问或需要更多信息，可以联系我们 yonghu@yicai.com 随着中国老龄化的加剧，前列腺增生（BPH）的 ...

Once again, the topics of lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) received a great deal of attention at this year's meeting of the American Urological Association ...

New York, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment ...

Benign prostatic hyperplasia (BPH) is an extremely common disease of older men, occurring in more than 70 percent of men over the age of 60. BPH results in substantial morbidity in this patient ...

The goals of therapy for BPH are to ameliorate LUTS, prevent related complications, and achieve measurable improvement in the patient's QOL. 3 In addition to drug and resource utilization costs, ...

Benign prostatic hyperplasia (BPH) is one of the most common urologic conditions affecting men as they age, with nearly 50% of men over 50 experiencing symptoms. Despite its prevalence, treatment ...

The treatment of benign prostatic hyperplasia (BPH) that causes lower urinary tract symptoms has advanced enormously since the days when it was a simple choice between no treatment with reassurance, ...

Our extensive research on the Benign Prostatic Hyperplasia Treatment (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, in ...